Search Within

Kevin Joseph Curran

  1. "2017"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (1)
Groups
  1. Center for Hematologic Malignancies (8)
  2. Department of Medicine (8)
  3. Pediatrics, Department of (8)
  4. Stem Cell Transplantation and Cellular Therapy Service (8)
  5. GSK Faculty (7)
  6. Hematologic Malignancies, Division of (7)

More Groups

People
  1. Renier Brentjens (5)
  2. Craig Sauter (4)
  3. Isabelle Riviere (4)
  4. Jae Park (4)
  5. Barbara Spitzer (3)
  6. Carolyn Jackson (3)

More People

Years
  1. 2017 (8)
Publications
  1. Blood (4)
  2. Bone Marrow Transplantation (1)
  3. Hematological Oncology (1)
  4. Leukemia (1)
  5. Molecular Therapy (1)
Publishers
  1. American Society of Hematology (4)
  2. Nature Publishing Group (3)
  3. Wiley Blackwell (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Development and evaluation of a human single chain variable fragment (scFv) derived BCMA targeted CAR T Cell vector leads to a high objective response rate in patients with advanced MM
    Meeting Abstract

    Smith, E. L.; Mailankody, S.; Ghosh, A.; Masakayan, R.; Staehr, M.; Purdon, T. J.; Halton, E.; Diamonte, C.; Anant, P.; Bernal, Y.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Enhancing CAR T cell anti-tumor efficacy through secreted single chain variable fragment (scFv) immune checkpoint blockade
    Meeting Abstract

    Rafiq, S.; Jackson, H. J.; Yeku, O.; Purdon, T. J.; van Leeuwen, D. G.; Curran, K. J.; Ahmed, R. N.; Cullen, G. D.; Yan, S.; Wang, P.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Brentuximab vedotin plus bendamustine is an effective salvage regimen for pediatric patients with relapsed Hodgkin lymphoma
    Meeting Abstract

    Gulati, N.; Boulad, F.; Cancio, M. I.; Curran, K. J.; Jackson, C.; Kernan, N.; Kung, A. L.; O'Reilly, R.; Prockop, S.; Ramaswamy, K.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • High dose cyclophosphamide and pre-treatment disease burden dictate response and survival in a multicenter clinical trial using CD19-specific CAR T cells for relapsed/refractory B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Park, J. H.; Sauter, C. S.; Smith, E. L.; Boulad, F.; Cancio, M. I.; Forlenza, C.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Radiation-free cytoreductive regimens and T-cell depleted allogeneic stem cell transplants (HSCT) for the treatment of 65 pediatric patients with hematologic malignancies
    Meeting Abstract

    Boulad, F.; Kernan, N. A.; Prockop, S. E.; Kobos, R.; Judge, A.; Cancio, M.; Curran, K. J.; Jackson, C. C.; Spitzer, B.; Koehne, G.; more...
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Novel PDGFRB fusions in childhood B- and T-acute lymphoblastic leukemia
    Journal Article

    Heilmann, A. M.; Schrock, A. B.; He, J.; Nahas, M.; Curran, K.; Shukla, N.; Cramer, S.; Draper, L.; Verma, A.; Erlich, R.; more...
    Leukemia (2017)

    Fulltext@MSK | Save
  • A Phase I trial of 19-28z CAR-T cells post-high dose therapy and autologous transplantation (HDT-ASCT) for relapsed and refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL)
    Meeting Abstract

    Sauter, C.; Riviere, I.; Senechal, B.; Ni, A.; Bernal, Y.; Wang, X.; Purdon, T.; Hall, M.; Moskowitz, C.; Giralt, S.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Disease burden and transplant on long-term survival after CD19 CAR T cells in adults with relapsed acute lymphoblastic leukemia
    Meeting Abstract

    Park, J.; Rivere, I.; Wang, X. Y.; Senechal, B.; Curran, K.; Sauter, C.; Wang, Y. Z.; Li, D.; Brentjens, R.; Sadelain, M.
    Molecular Therapy (2017)

    Fulltext@MSK | Save